BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28222330)

  • 1. Hereditary C1 inhibitor deficiency is associated with high spontaneous amidase activity.
    Charignon D; Ghannam A; Ponard D; Drouet C
    Mol Immunol; 2017 May; 85():120-122. PubMed ID: 28222330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.
    Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
    Mol Immunol; 2020 Mar; 119():27-34. PubMed ID: 31955064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay.
    Ghannam A; Sellier P; Defendi F; Favier B; Charignon D; López-Lera A; López-Trascasa M; Ponard D; Drouet C
    Allergy; 2015 Sep; 70(9):1103-11. PubMed ID: 26010015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes.
    Ponard D; Gaboriaud C; Charignon D; Ghannam A; Wagenaar-Bos IGA; Roem D; López-Lera A; López-Trascasa M; Tosi M; Drouet C
    Hum Mutat; 2020 Jan; 41(1):38-57. PubMed ID: 31517426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.
    Christiansen SC; Zuraw BL
    Immunol Allergy Clin North Am; 2024 Aug; 44(3):543-560. PubMed ID: 38937015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype.
    Charignon D; Ghannam A; Defendi F; Ponard D; Monnier N; López Trascasa M; Launay D; Caballero T; Djenouhat K; Fain O; Cichon S; Martin L; Drouet C
    Allergy; 2014 Dec; 69(12):1659-65. PubMed ID: 25134986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and laboratory diagnosis of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current update on cellular and molecular mechanisms of hereditary angioedema.
    Walford HH; Zuraw BL
    Ann Allergy Asthma Immunol; 2014 May; 112(5):413-8. PubMed ID: 24484972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic assays for the diagnosis of bradykinin-dependent angioedema.
    Defendi F; Charignon D; Ghannam A; Baroso R; Csopaki F; Allegret-Cadet M; Ponard D; Favier B; Cichon S; Nicolie B; Fain O; Martin L; Drouet C;
    PLoS One; 2013; 8(8):e70140. PubMed ID: 23940538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema.
    Frazer-Abel A; Giclas PC
    Allergy Asthma Proc; 2011; 32 Suppl 1():17-21. PubMed ID: 22195757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
    Busse P; Kaplan A
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations.
    Kang HR; Yim EY; Oh SY; Chang YS; Kim YK; Cho SH; Min KU; Kim YY
    Allergy; 2006 Feb; 61(2):260-4. PubMed ID: 16409206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
    Veronez CL; Christiansen SC; Smith TD; Riedl MA; Zuraw BL
    Allergy Asthma Proc; 2021 Nov; 42(6):506-514. PubMed ID: 34871158
    [No Abstract]   [Full Text] [Related]  

  • 15. SERPING1 mutations in 59 families with hereditary angioedema.
    López-Lera A; Garrido S; Roche O; López-Trascasa M
    Mol Immunol; 2011 Oct; 49(1-2):18-27. PubMed ID: 21864911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema.
    Gösswein T; Kocot A; Emmert G; Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Bork K; Oldenburg J; Müller CR
    Cytogenet Genome Res; 2008; 121(3-4):181-8. PubMed ID: 18758157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1.
    Karadža-Lapić L; Korošec P; Šilar M; Košnik M; Cikojević D; Lozić B; Rijavec M
    Ann Med; 2016 Nov; 48(7):485-491. PubMed ID: 27187751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target levels of functional C1-inhibitor in hereditary angioedema.
    Hack CE; Relan A; van Amersfoort ES; Cicardi M
    Allergy; 2012 Jan; 67(1):123-30. PubMed ID: 21923668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.
    Steiner UC; Keller M; Schmid P; Cichon S; Wuillemin WA
    Clin Exp Immunol; 2017 Jun; 188(3):430-436. PubMed ID: 28194776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor C4 activation in patients with hereditary angioedema.
    Aabom A; Bygum A; Koch C
    Clin Biochem; 2017 Oct; 50(15):816-821. PubMed ID: 28412283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.